Ashland to introduce new GMP hot-melt extruder
The 18mm Leistritz extruder helps make the drugs more soluble with dispersions from Ashland, thereby scaling up to GMP clinical and commercial quantities produced by hot-melt extrusion. Ashland
The US Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals’ Livsayis (cemdisiran) to treat generalised myasthenia gravis (gMG) in adult patients positive for anti-acetylcholine receptor (AChR) antibodies.
Regorafenib is an oral multi-kinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases (TK) used for the treatment of metastatic colorectal cancer (mCRC). The double-blind, international, multicenter,